Interrogating the Dimerization Interface of the Prion Protein Via Site-Specific Mutations to

Sudheer Babu Sangeetham1, Krisztina Huszár2, Petra Bencsura2

  • 1Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.

Insights

Researchers investigated prion protein (PrP) oligomerization, a key process in transmissible spongiform encephalopathies. They identified specific regions of the N-terminal part of the mouse prion protein (mPrP) as crucial for dimer formation during this process.

Area of Science:

  • Biochemistry
  • Structural Biology
  • Neuroscience

Background:

  • Transmissible spongiform encephalopathies (TSEs) involve prion protein (PrP) misfolding from helical monomers to beta-sheet-rich aggregates.
  • The exact mechanism of infectious and toxic oligomer formation from PrP monomers remains unclear.

Purpose of the Study:

  • To investigate the structural basis of prion protein dimer formation, a potential intermediate in oligomerization.
  • To identify the specific regions of the prion protein involved in dimer interfaces.

Main Methods:

  • Creation of 25 mouse prion protein (mPrP) variants with site-specifically incorporated para-benzoyl-phenylalanine (pBpa), a cross-linkable non-natural amino acid.
  • Utilizing pBpa cross-linking to probe the dimer interface of mPrP.

Main Results:

  • The N-terminal region of the prion protein, particularly residues near positions 127 and 107, is integral to the dimer interface.
  • These findings provide insights into the initial steps of PrP oligomerization.

Conclusions:

  • The N-terminal regions of mPrP are critical for forming dimers, a likely step in prion protein aggregation.
  • pBpa-containing mPrP variants offer a valuable tool for further structural studies of pathogenic PrP species.

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.8K
Protein-Protein Interfaces02:04

Protein-Protein Interfaces

4.5K
Mutations01:39

Mutations

Overview
94.6K
Mutations01:35

Mutations

Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
44.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
40.0K
Mutation, Gene Flow, and Genetic Drift01:09

Mutation, Gene Flow, and Genetic Drift

In a population that is not at Hardy-Weinberg equilibrium, the frequency of alleles changes over time. Therefore, any deviations from the five conditions of Hardy-Weinberg equilibrium can alter the genetic variation of a given population. Conditions that change the genetic variability of a population include mutations, natural selection, non-random mating, gene flow, and genetic drift (small population size).
64.6K